Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 8:49 pm Sale | 2025-07-09 | 13G | ACUTUS MED INC AFIB | Advent Life Sciences LLP | 22,757 0.076% | -1,596,614 (-98.59%) | Filing History |
| 2026-02-17 8:48 pm Purchase | 2026-02-13 | 13G | AURA BIOSCIENCES INC AURA | Advent Life Sciences LLP | 2,071,857 3.335% | 48,000 (+2.37%) | Filing History |
| 2024-08-20 8:13 pm Purchase | 2024-08-20 | 13D | ELOXX PHARMACEUTICALS INC ELOX | Advent Life Sciences LLP | 124,972 3.980% | 61,665 (+97.41%) | Filing History |
| 2022-02-11 6:04 pm Unchanged | 2021-12-31 | 13G | ACUTUS MED INC AFIB | Advent Life Sciences LLP | 1,619,371 5.800% | 0 (Unchanged) | Filing History |
| 2022-02-11 5:59 pm Purchase | 2021-12-31 | 13G | AURA BIOSCIENCES INC AURA | Advent Life Sciences LLP | 2,023,857 6.900% | 2,023,857 (New Position) | Filing History |